
ã³ãããã¯ã¯ãã³æ¥çš®åŸã«1700äžäººãæ»äº¡ãããšããé©ç°çãªç ç©¶çµæã
å èšäºã¯ãã¡ããã/Click here to read the original article.
ç»æçãªç ç©¶ã«ãããã³ããããã¯ã¯ãã³ãæ¥çš®åŸã«äžçäžã§1,700äžäººãæ»äº¡ããŠããããšã倿ãããããã©ãããããã®ç ç©¶ã¯æ€é²ãããŠããïŒããã¹ã»ã©ã³ã¯ãŒã«å士ãããªãŒãã»ããŒãã³å士ããžã§ã»ãã»ããããŒå士ããžã§ã¬ããŒã»ã¡ã«ã·ãšå士ã«ããè¡æçãªç ç©¶ãååçã«ãããCOVID-19ã¯ã¯ãã³ã«é¢é£ããæ»äº¡çãã¯ã2023幎9æ17æ¥ã«çºè¡šããããããããŸãè¡æçãªããšã«ããã®ç ç©¶ã¯æ³šç®ãããã«å€ãããã®ã§ã¯ãªããæ€é²ãšããŸã ãã¹ããããŠããªãCovid-19 "ã¯ã¯ãã³ "ã®å®å šæ§ãšæå¹æ§ã«é¢ãããç©èªã確èªãããã㪠"äºå®ç¢ºèª "ã«ããå¿ããŠããªãããœãŒã¹
ç ç©¶
å»åž«å£ã¯4倧éžãã©ãã³ã¢ã¡ãªã«ãèµ€éçŽäžã®17ã«åœã調æ»ãããã©ã³ã³ãŒãå士ã¯ããå šäžçã§æ¥çš®ãããã¯ã¯ãã³ã®æ¯æ§ãèšç®ããçµæã1700äžäººããã®ã¯ã¯ãã³ã«ãã£ãŠæ»äº¡ãããšçµè«ã¥ããŸããããšèª¬æããã
17ã«åœã4倧éž
èµ€éçŽäžãšååçã®17ã«åœïŒ ã¢ã«ãŒã³ãã³ããªãŒã¹ãã©ãªã¢ãããªãã¢ããã©ãžã«ãããªãã³ãã³ãã¢ããšã¯ã¢ãã«ããã¬ãŒã·ã¢ããã¥ãŒãžãŒã©ã³ãããã©ã°ã¢ã€ããã«ãŒããã£ãªãã³ãã·ã³ã¬ããŒã«ãåã¢ããªã«ãã¹ãªãã ãã¿ã€ããŠã«ã°ã¢ã€ã

4倧éžã«ãŸããããããã®åœã ã¯ãäžç人å£ã®9.10ïŒ ãäžçã®COVID-19泚å°ã®10.3ïŒ ïŒ1人åœããã®æ¥çš®ç1.91åãå šå¹Žéœ¢ïŒãäºå®äžãã¹ãŠã®COVID-19ã¯ã¯ãã³ã®çš®é¡ãšè£œé æ¥è ããæ§æãããŠããã
ã³ããã¯ã¯ãã³ã«æçãªå¹æã¯ãªãã£ãã
17ã«åœã«ãããŠãCOVID-19ã¯ã¯ãã³ã«ããæçãªå¹æããã£ããšããæéããŒã¿ã«ããå šæ»å æ»äº¡çïŒACMïŒã®èšŒæ ã¯ãªããCOVID-19ã¯ã¯ãã³æ¥çš®ãšå šæ»å æ»äº¡çïŒACMïŒã®æ¯äŸçæžå°ãšã®éã«æéçãªé¢é£ã¯ãªãã
å®éã«ã¯ãã®éã§ããã17ã«åœãã¹ãŠã§ãCOVID-19ã¯ã¯ãã³ãé åã»æ¥çš®ããããšãå šæ»å æ»äº¡çïŒACMïŒã«é«ãæ°å€ãèŠãããã
17ã«åœã®ãã¡9ã«åœã¯ãäžçä¿å¥æ©é¢ïŒWHOïŒã2020幎3æ11æ¥ã«ãã³ãããã¯å®£èšãåºããŠããã¯ã¯ãã³ãå±éããããŸã§ã®çŽ1幎éãéå°ãªACMãæ€åºãããªãã£ãïŒãªãŒã¹ãã©ãªã¢ããã¬ãŒã·ã¢ããã¥ãŒãžãŒã©ã³ãããã©ã°ã¢ã€ããã£ãªãã³ãã·ã³ã¬ããŒã«ãã¹ãªãã ãã¿ã€ããŠã«ã°ã¢ã€ïŒãåºå ž
ããŒã¹ã¿ãŒãå šæ»å æ»äº¡çãé«ãã
調æ»ã«ãããšãã2022幎ã®å€ïŒ1æïœ2æïŒã«ååçãšèµ€éçŽäžã®åœã ã§ACMã®åäŸã®ãªãããŒã¯ãçºçããŠããããããã®ããŒã¯ã¯ãCOVID-19-ã¯ã¯ãã³ã»ããŒã¹ã¿ãŒæäžïŒ3åç®ãŸãã¯4åç®ïŒã®æ¥éãªå±éãšåæããŠãããããŸãã¯ãã®çŽåã§ãããç ç©¶è ãã¡ã«ããã°ããã®çŸè±¡ã¯ååãªæ»äº¡çããŒã¿ããããã¹ãŠã®ã±ãŒã¹ã«èŠããããšããïŒã¢ã«ãŒã³ãã³ãšã¹ãªãã ã§ã¯2022幎1æïœ2æã®æ»äº¡çããŒã¿ãäžååã ã£ãïŒã
ç ç©¶ãè¡ã£ãå»åž«ãã¡ã«ãããšããååçãšèµ€éçŽäžã®17ã«åœãã¹ãŠã«ãããŠãCOVID-19ã¯ã¯ãã³ã®å±éãšæç¶çãªæäžãšæãåããããŠãé«ACMã®äœå¶ã«ç§»è¡ããããšã¯ãã¯ã¯ãã³ä»¥å€ã®åå ã«ãããã®ãšã¯èãã«ãã ããšãããåºå ž
æ»äº¡çã¯å¹Žéœ¢ãšãšãã«äžæ
ACMã®å€ãã®ããŒã¯ïŒ17ã«åœã4倧éžããã¹ãŠã®é«éœ¢è 幎霢局ãç°ãªãææïŒãšããã«é¢é£ããæ¥éãªããŒã¹ã¿ãŒå±éã®éã®å ±ææ§ã«ãããå æé¢ä¿ã«é¢ãããã®ç¢ºåºãšããçµè«ãšCOVID-19-ã¯ã¯ãã³ã®æ¯æ§ã®æ£ç¢ºãªå®éåãå¯èœã«ãªã£ãããšå»åž«ãã¡ã¯è¿°ã¹ãŠãããåºå ž
å
šå¹Žéœ¢ã®ã¯ã¯ãã³æäžèŽæ»çïŒVDFRïŒã¯ãããéå£ã§æäžãããã¯ã¯ãã³éã«å¯Ÿããã¯ã¯ãã³èªçºæ»äº¡ã®æšå®æ¯çã§ããã2022幎1æïœ2æã®ACMããŒã¯ã§ã¯0.02ïŒ
ïŒãã¥ãŒãžãŒã©ã³ãïŒãã0.20ïŒ
ïŒãŠã«ã°ã¢ã€ïŒã®ç¯å²ã«åãŸãããšãå®éåãããŠããã
(ãŠã«ã°ã¢ã€ïŒãããªãšãã«ãŒã§ã¯ãã¯ã¯ãã³æäžã«ããæ»äº¡çã¯å¹Žéœ¢ãšãšãã«ææ°é¢æ°çã«å¢å ãïŒçŽ4æ³ããšã«çŽ2åïŒãææ°ã®ããŒã¹ã¿ãŒæäžã§æå€§ãšãªãã90æ³ä»¥äžã®å¹Žéœ¢å±€ã§çŽ5ïŒ
ã«éããïŒæäž4åç®ã®æ³šå°20åã«ã€ã1äººãæ»äº¡ïŒã(ç ç©¶è
ã«ããã°ãååçïŒã€ã³ããã€ã¹ã©ãšã«ãç±³åœïŒã®ç ç©¶çµæã«ã广µããïŒ
1700äžäººã®æ»
ç ç©¶ããŒã ã¯ã17ã«åœã®å šå¹Žéœ¢ã¯ã¯ãã³æäžèŽæ»çïŒVDFRïŒãïŒ0.126±0.004ïŒïŒ ãšå®éåãããããã¯ã2023幎9æ2æ¥ãŸã§ã®135.0ååã®æ³šå°ã«ãããå šäžçã§170.0±0.5çŸäžäººã®COVID-19ã¯ã¯ãã³ã«ããæ»äº¡ãæå³ãããåºå ž
Rancourtãã¯ãã³ããã¯ã¯ãã³ã«ããæ»äº¡ã¯ãäžç人å£ã®ïŒ0.213±0.006ïŒïŒ ãæ»äº¡ããã倧éç°ææ§äºè±¡ã«çžåœãããçããŠãã470人ããã1人ã3幎以å ã«æ»äº¡ããŠããã
å®éã®éå£ã«ãããCOVID-19ã¯ã¯ãã³ã®æ³šå°ã«ããæ»äº¡ã®å šäœçãªãªã¹ã¯ã¯ãéå°ãªå šæ»å æ»äº¡çãšãã®å±éãšã®å ±ææ§ããæšæž¬ãããããã«ãäžççã«åºç¯ã§ãããèšåºè©Šéšãå¯äœçšã¢ãã¿ãªã³ã°ãæ»äº¡èšºææžããã®æ»å çµ±èšã§å ±åãããŠãããããã¯ããã«å€§ããã3æ¡ïŒ1,000åïŒã倧ãããåºå ž



ãã®ä»å€ãã®ã°ã©ããšçµæã¯ããã¡ããã芧ãã ãã - Rancourt Study 17m Deaths All Cause Deathality Southern Hemisphere 23.5MB ã» PDFãã¡ã€ã«ããŠã³ããŒã
èŠçŽãããš
ãã³ããã㯠"æéäžã4倧éž17ã«åœã®å€§éšåã§ "ã³ããã "ã¯å šæ»å æ»äº¡çãäžåããªãã£ããåŸã£ãŠããã®ã±ãŒã¹ã ãã§äºæ³ãããããã«ã"ã³ããã "ã¯ã¯ãã³ã«ã¯æçãªå¹æã¯ãªãã£ãã
ãã®ç ç©¶ã§ã¯ãå šæ»å æ»äº¡çã«ããŒã¯ã芳å¯ããããã®ããŒã¯ã¯ããŒã¹ã¿ãŒã¯ã¯ãã³ã®3åç®ãš4åç®ã®æ¥çš®ãšäžèŽããŠããã4倧éžã«ãŸããã17ã«åœã®ãã¹ãŠã§ãã¯ã¯ãã³æ¥çš®åŸããã¹ãŠã®å¹Žéœ¢ã®é«éœ¢è ã®æ»äº¡ã«ããŒã¯ãçããã¯ã¯ãã³ã«ããé«éœ¢è ã®æ»äº¡ã¯ææ°é¢æ°çã«å¢å ããçŽ4æ³ããšã«çŽ2åã«ãªã£ããããã¯å¶ç¶ã®äžèŽã§ã¯ãªãã
ã«ãŒããã¢åœäŒã§éå¬ãããåœé屿©ãµããã4ã§å»åž«ãã¡ãã€ã³ã¿ãã¥ãŒãåããŠãããäžã®ãããª
ä»ãšãªã£ãŠã¯ããããã®ã¯ã¯ãã³ãæåããããšã®å±éºæ§ãçãäœå°ã¯ãªãã¯ãã§ããã補è¬äŒç€Ÿã®è£œåã "å®å šã§å¹æç "ãšã¯ã»ã©é ãããšãäžçäžã®æå°è ãã¡ãèªèããŠããããšãçãäœå°ããªãã¯ãã§ããã
å°æ¬ãã¹ãç§åŠè ãã¡ã«ããç ç©¶çµæã«ã·ã§ãã¯ãåããŠããªãããã«èŠããã®ã¯ããã以å€ã«èª¬æãã€ããªãã圌ãã¯ãŸãããã®ç ç©¶çµæãæ€é²ããäœã®è°è«ãããã« "äºå®ç¢ºèª "ããããšãæãã§ããã
圌ãã¯åžžã«ç¥ã£ãŠããŠãèŽåœçãªãžã£ããäžçäžã«æäžããããšã«äœã®ãããããæããªãã£ããšèãããããªãã圌ãã¯ä»ãèªåãã¡ã®è¡åã®çã®æªãä»ã®ãã¹ãŠã®äººã ã«ç¥ãããã®ãé²ãããã«å šåãå°œãããŠããã